Press Release:
Visualase To Be Awarded $2.1 Million For Research.
Visualase Inc. was selected for a $2.1 million grant from the Cancer Prevention and Research Institute of Texas. The Visualase technology has made possible the ablation of tissue in areas such as brain and prostate.
FDA Statement